Michael G Stabin

Publications (7)22.66 Total impact

• Article: SNM practice guideline for lung scintigraphy 4.0.

  J Anthony Parker, R Edward Coleman, Erin Grady, Henry D Royal, Barry A Siegel, Michael G Stabin, H Dirk Sostman, Andrew J W Hilson
  Journal of Nuclear Medicine Technology 03/2012; 40(1):57-65.
• Article: The SNM practice guideline for somatostatin receptor scintigraphy 2.0.

  Helena R Balon, Tracy L Y Brown, Stanley J Goldsmith, Edward B Silberstein, Eric P Krenning, Otto Lang, Gary Dillehay, Jennifer Tarrance, Matt Johnson, Michael G Stabin
  [show abstract] [hide abstract]
  ABSTRACT: VOICE Credit: This activity has been approved for 1.0 VOICE (Category A) credit. For CE credit, participants can access this activity on page ▪▪ or on the SNM Web site (http://www.snm.org/ce_online) through December 31, 2013. You must answer 80% or the questions correctly to receive 1.0 CEH (Continuing Education Hour) credit.
  Journal of Nuclear Medicine Technology 11/2011; 39(4):317-24.
• Source

  Available from: ccsnm.org

  Article: SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0.

  George Segall, Dominique Delbeke, Michael G Stabin, Einat Even-Sapir, Joanna Fair, Rebecca Sajdak, Gary T Smith
  Journal of Nuclear Medicine 11/2010; 51(11):1813-20. · 6.38 Impact Factor
• Article: SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0.

  Stanley J Goldsmith, Ward Parsons, Milton J Guiberteau, Lillian H Stern, Leora Lanzkowsky, Jean Weigert, Thomas F Heston, Elizabeth Jones, Jonathan Buscombe, Michael G Stabin
  [show abstract] [hide abstract]
  ABSTRACT: VOICE Credit: This activity has been approved for 1.0 VOICE (Category A) credits. For CE credit, participants can access this activity on page ▪▪▪ or on the SNM Web site (http://www.snm.org/ce_online) through December 31, 2012. You must answer 80% of the questions correctly to receive 1.0 CEH (Continuing Education Hour) credit.
  Journal of Nuclear Medicine Technology 11/2010; 38(4):219-24.
• Source

  Available from: snmjournals.org

  Article: SNM practice guideline for hepatobiliary scintigraphy 4.0.

  Mark Tulchinsky, Brian W Ciak, Dominique Delbeke, Andrew Hilson, Kelly Anne Holes-Lewis, Michael G Stabin, Harvey A Ziessman
  [show abstract] [hide abstract]
  ABSTRACT: VOICE Credit: This activity has been approved for 1.0 VOICE (Category A) credits. For CE credit, participants can access this activity on page ▪▪▪ or on the SNM Web site (http://www.snm.org/ce_online) through December 31, 2012. You must answer 80% of the questions correctly to receive 1.0 CEH (Continuing Education Hour) credit.
  Journal of Nuclear Medicine Technology 11/2010; 38(4):210-8.
• Article: Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

  Jonathan S Wall, Stephen J Kennel, Alan C Stuckey, Misty J Long, David W Townsend, Gary T Smith, Karen J Wells, Yitong Fu, Michael G Stabin, Deborah T Weiss, Alan Solomon
  [show abstract] [hide abstract]
  ABSTRACT: Care of patients with AL amyloidosis currently is limited by the lack of objective means to document disease extent, as well as therapeutic options that expedite removal of pathologic deposits. To address these issues, we have initiated a Phase I Exploratory IND study to determine the biodistribution of the fibril-reactive, amyloidolytic murine IgG1 mAb 11-1F4 labeled with I-124. Patients were infused with less than 1 mg (∼ 74 MBq) of GMP-grade antibody and imaged by PET/CT scan 48 and 120 hours later. Among 9 of 18 subjects, there was striking uptake of the reagent in liver, lymph nodes, bone marrow, intestine, or, unexpectedly, spleen (but not kidneys or heart). Generally, positive or negative results correlated with those obtained immunohistochemically using diagnostic tissue biopsy specimens. Based on these findings, we posit that (124)I-mAb m11-1F4 can be used to identify AL candidates for passive immunotherapy using the chimeric form of the antibody.
  Blood 09/2010; 116(13):2241-4. · 9.90 Impact Factor
• Source

  Available from: psu.edu

  Article: Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

  Dominique Delbeke, R Edward Coleman, Milton J Guiberteau, Manuel L Brown, Henry D Royal, Barry A Siegel, David W Townsend, Lincoln L Berland, J Anthony Parker, Karl Hubner, Michael G Stabin, George Zubal, Marc Kachelriess, Valerie Cronin, Scott Holbrook
  Journal of Nuclear Medicine 06/2006; 47(5):885-95. · 6.38 Impact Factor